Evidence map›Paper›PMID 41168484›Full record

ArticleAAPS PharmSciTech2025

Multistep Machine Learning Pipeline For Polymeric Nanoparticle Design.

Rodrigo Fonseca Silveira, Ingrid Araujo de Santana, Ana Luiza Lima, Idejan Padilha Gross, Tais Gratieri, Guilherme Gelfuso, Marcilio Cunha-Filho

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rodrigo Fonseca SilveiraLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil.ORCID http://orcid.org/0000-0003-4965-8519
Ingrid Araujo de SantanaLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil.ORCID http://orcid.org/0009-0007-0173-2800
Ana Luiza LimaLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil.ORCID http://orcid.org/0000-0002-2177-8941
Idejan Padilha GrossLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil.ORCID http://orcid.org/0000-0002-1798-7927
Tais GratieriLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil.ORCID http://orcid.org/0000-0001-6481-2364
Guilherme GelfusoLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil.ORCID http://orcid.org/0000-0002-1924-7885
Marcilio Cunha-FilhoLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia (UnB), Brasília, 70910-900, Brazil. marciliofarm@hotmail.com.ORCID http://orcid.org/0000-0002-9167-6852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating machine learning (ML) into nanotechnology represents a promising strategy for rational design and accelerated development of drug delivery systems. However, studies in this field are scarce and face methodological and interpretative problems. This study presents a modular ML pipeline for the predictive modeling of nanoparticles produced via nanoprecipitation using isoniazid as a model drug. The workflow was structured into three sequential steps: (1) binary classification to predict nanoparticle formation, (2) multiclass classification to estimate size ranges, and (3) regression to refine size prediction. Several algorithms were used, including Extreme Gradient Boosting, Random Forest, Artificial Neural Networks (ANN), Generalized Linear Models, and Naive Bayes. A total of 90 formulations were evaluated over three iterative experimental rounds. In each cycle, models were retrained with new data and used to simulate virtual formulations, thereby guiding the selection of experiments to reduce data imbalance and improve prediction accuracy. The ANN algorithm consistently outperformed other models in all steps, achieving an R

Indexed as

Machine LearningNanoparticlesPolymersAlgorithmsBayes TheoremChemistry, PharmaceuticalDrug Delivery SystemsDrug DesignIsoniazidNanotechnologyNeural Networks, ComputerParticle SizeReproducibility of ResultsIsoniazidPolymersartificial neural networkdata sciencedrug deliverymachine learningnanoprecipitationpolymeric nanoparticlequality by design

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.